Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atara Biotherapeutics, Inc. | 31,688 | reported | 26 Mar 2019 | tx 14+222,459−57,650 |
| Acumen Pharmaceuticals, Inc. | 12,800 | reported | 04 Jun 2025 | tx 5+132,300 |
| Passage BIO, Inc. | 10,539 | reported | 19 May 2026 | tx 6+341,925 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Passage BIO, Inc. | 10,539 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Acumen Pharmaceuticals, Inc. | 12,800 | 0.00 USD | |
| 04 Jun 2025 | GRANT_AWARD | Acumen Pharmaceuticals, Inc. | 19,500 | 0.00 USD | deriv |
| 28 May 2025 | GRANT_AWARD | Passage BIO, Inc. | 201,857 | 0.00 USD | deriv |
| 10 Jun 2024 | GRANT_AWARD | Acumen Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 21 May 2024 | GRANT_AWARD | Passage BIO, Inc. | 47,693 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | Acumen Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 25 May 2023 | GRANT_AWARD | Passage BIO, Inc. | 24,000 | 0.00 USD | deriv |
| 04 Jan 2023 | GRANT_AWARD | Acumen Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
| 26 May 2022 | GRANT_AWARD | Passage BIO, Inc. | 24,000 | 0.00 USD | deriv |
| 27 May 2021 | GRANT_AWARD | Passage BIO, Inc. | 33,836 | 0.00 USD | deriv |
| 26 Mar 2019 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 10,000 | 0.00 USD | |
| 15 Feb 2019 | EXERCISE | Atara Biotherapeutics, Inc. | 4,000 | 14.30 USD | |
| 15 Feb 2019 | SALE | Atara Biotherapeutics, Inc. | 5,909 | 40.00 USD | |
| 15 Feb 2019 | EXERCISE | Atara Biotherapeutics, Inc. | 4,000 | 0.00 USD | deriv |
| 06 Feb 2019 | TAX_WITHHOLDING | Atara Biotherapeutics, Inc. | 1,216 | 38.47 USD | |
| 06 Feb 2019 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 12,313 | 0.00 USD | |
| 06 Feb 2019 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 24,625 | 0.00 USD | deriv |
| 15 May 2018 | SALE | Atara Biotherapeutics, Inc. | 16,334 | 45.02 USD | |
| 15 May 2018 | EXERCISE | Atara Biotherapeutics, Inc. | 16,334 | 14.30 USD | |
| 15 May 2018 | EXERCISE | Atara Biotherapeutics, Inc. | 16,334 | 0.00 USD | deriv |
| 08 May 2018 | SALE | Atara Biotherapeutics, Inc. | 1,544 | 40.15 USD | |
| 06 Feb 2018 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 12,500 | 0.00 USD | |
| 06 Feb 2018 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 10 May 2017 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 130,000 | 0.00 USD | deriv |